Contamination Control Strategy (CCS) Under EU GMP Annex 1
From The GMP Insider · 15:07
Show by Tushar Arora
Most contamination control strategies fail on page one — not because anything in them is wrong, but because everything in them is copied from somewhere else. Marcus and Priya break down the CCS under EU GMP Annex 1: what it actually has to contain, how facility design, people, sterilisation, media fills, monitoring, and disinfection connect into one risk-based argument, the five failure patterns inspectors find again and again, and how to keep the strategy alive instead of letting it become a static binder.• What a CCS is under Annex 1 — planned controls for microorganisms, particles, and pyrogens, built on ICH Q9 risk management• Start with sources, not solutions: people, materials, air, utilities, and the process itself — prevention, detection, and response for each• First air: what it is, how interventions break it, and why design and training must protect it• People, gowning, and behaviour: qualification, monitoring, and what a bad trend must trigger• Process controls: sterilisation, PUPSIT, validated material transfer, and the media fill as the strategy's exam• Monitoring and disinfection as the feedback loop: trending, alert vs action limits, and disinfectant efficacy against site flora• The five failures inspectors actually find: template strategies, static documents, missing interactions, monitoring divorced from action, and rationale gaps• Keeping the strategy alive: event-based review triggers, a named owner, and sterility metrics in front of leadershipNew episodes every Monday and Wednesday — follow The GMP Insider so you never miss one.Connect with Tushar Arora on LinkedIn: https://www.linkedin.com/in/tushar-a-926382161Watch on YouTube: https://www.youtube.com/@TheGMPInsiderProduced with AI assistance.
More episodes of The GMP Insider
More episodes
- Environmental Monitoring: Alert vs Action Limits & Trending
- ICH Q9(R1) Quality Risk Management: What's Actually New
- Change Control Management: What Gets Companies in Trouble
- Deviation Investigation & Root Cause Analysis: 5 Whys Done Right
- How to Respond to an FDA 483 (and Warning Letter) in 15 Working Days
- FDA Inspection Readiness 2026: The New Cross-System Inspection Model
- Why FDA Rejects Your CAPA: 5 CAPA Effectiveness Failures Explained
- Why FDA Rejects Your CAPA: 5 CAPA Effectiveness Failures Explained
- OOS Investigation Explained: Phase 1 vs Phase 2 (21 CFR 211.192)
- ALCOA+ Explained: The 9 Data Integrity Principles FDA Actually Cites
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.